Venetoclax, Cladribine, Idarubicin, Cytarabine Regimen Evaluated in AML, High-Risk MDS
Omacetaxine Plus Azacitidine for Excess Blasts-MDS: Safety, Long-Term Outcomes Favorable
Decitabine Plus All-Trans Retinoic Acid Evaluated in Excess-Blasts MDS